NCT01194245: Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus |
|
|
| Completed | 2 | 135 | US | Insulin lispro, Humalog, recombinant human hyaluronidase PH20, Hylenex, rHuPH20, PH20, Insulin aspart, Insulin glulisine, Apidra, Insulin glargine, Lantus | Halozyme Therapeutics | Diabetes Mellitus, Type 1 | 08/11 | 08/11 | | |
SHAN, NCT02509429: Comparison of an Artificial Pancreas Versus Threshold Low Glucose Suspend in Type 1 Diabetic Children |
|
|
| Completed | 2 | 24 | Europe | Insulin therapy (aspart, lispro ou glulisine) with Control-to-Range algorithm, Insulin therapy ((aspart, lispro ou glulisine) withThreshold Low Glucose Suspend | University Hospital, Montpellier | Type 1 Diabetes | 12/16 | 12/16 | | |
